A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness

NCT03163511 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus With Hypoglycemia

Interventions

COMBINATION_PRODUCT: VC-02 Combination Product

Sponsor

ViaCyte

Collaborators

[object Object]
[object Object]
[object Object]